The Cancer Letter

Inside information on cancer research and drug development

Vol.
31
No.
12
December 26, 2008Dec 26, 2008
Free
DOWNLOAD THE PDF

Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

Age Doesn’t Affect Survival After Bone Marrow Transplant

Lenalidomide Found Effective For Lymphoma In Phase II Trial

Intensive Chemo Equivalent To Transplant For MCL

Expanding Umbilical Cord Stem Cells Found Safe As Standard Transplant

Arzerra Promising For Heavily Pre-Treated CLL Patients

Dismissed Leukemia Drug Helps CLL, Clinical Trials Find

PDX Shows 27% Response In T-Cell Lymphoma In Study

Second-Generation CML Drugs Show Promise For Frontline

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

NCI Cooperative Group, Cancer Center Trials Listed

Login

Looking for IP Login?